Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04429594

Study of the Incidence of SARS-CoV-2 Infection (COVID-19)

Study of the Incidence of SARS-CoV-2 Infection in the Alpes-Maritimes Department by Analysis of the Specific Humoral and Cellular Response During Deconfinement

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
1,000 (estimated)
Sponsor
Centre Hospitalier Universitaire de Nice · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This is a prospective observational cohort study that will define the prevalence and incidence of CA-SARS-Cov2 infection using serological and PCR tests in a group of subjects during deconfinement. The team wishes to include approximately 1000 subjects in this study. The health crisis through containment has also created unprecedented environmental conditions with the very clear decrease in economic activities and a consequent decrease in exposure to the main air pollutants. The aim is therefore to carry out a case-control study in which each subject will be his or her own control in unexposed condition (to PM2.5, PM10, NO...) then exposed (after the recovery of economic activity and the usual levels of air pollutants) and to measure the impact of these pollutants on the immune system and epigenetic markers taking into account seasonality. The occurrence of infectious, cardiovascular, allergic and autoimmune events will then be measured according to the immunological profiles measured at inclusion.

Conditions

Interventions

TypeNameDescription
OTHERblood samplingblood sampling at J0, M6, M12, M24, M36, M48, M60

Timeline

Start date
2020-07-28
Primary completion
2025-07-15
Completion
2025-12-31
First posted
2020-06-12
Last updated
2024-06-27

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04429594. Inclusion in this directory is not an endorsement.